Praxis Precision Medicines (PRAX) Non-Current Deffered Revenue (2022 - 2024)
Historic Non-Current Deffered Revenue for Praxis Precision Medicines (PRAX) over the last 3 years, with Q3 2024 value amounting to $293000.0.
- Praxis Precision Medicines' Non-Current Deffered Revenue fell 8067.28% to $293000.0 in Q3 2024 from the same period last year, while for Sep 2024 it was $293000.0, marking a year-over-year decrease of 8067.28%. This contributed to the annual value of $1.2 million for FY2023, which is 4679.19% down from last year.
- Praxis Precision Medicines' Non-Current Deffered Revenue amounted to $293000.0 in Q3 2024, which was down 8067.28% from $588000.0 recorded in Q2 2024.
- In the past 5 years, Praxis Precision Medicines' Non-Current Deffered Revenue registered a high of $2.2 million during Q4 2022, and its lowest value of $293000.0 during Q3 2024.
- For the 3-year period, Praxis Precision Medicines' Non-Current Deffered Revenue averaged around $1.2 million, with its median value being $1.3 million (2023).
- Per our database at Business Quant, Praxis Precision Medicines' Non-Current Deffered Revenue crashed by 4679.19% in 2023 and then plummeted by 8067.28% in 2024.
- Quarter analysis of 3 years shows Praxis Precision Medicines' Non-Current Deffered Revenue stood at $2.2 million in 2022, then tumbled by 46.79% to $1.2 million in 2023, then plummeted by 74.76% to $293000.0 in 2024.
- Its Non-Current Deffered Revenue was $293000.0 in Q3 2024, compared to $588000.0 in Q2 2024 and $866000.0 in Q1 2024.